A trial of naxitamab and GM-CSF for high risk neuroblastoma
This trial is looking at naxitamab with GM-CSF to treat neuroblastoma that has continued to grow during treatment or has come back afterwards.
This trial is looking at naxitamab with GM-CSF to treat neuroblastoma that has continued to grow during treatment or has come back afterwards.
This study is looking at chemotherapy, radiotherapy and stem cell transplants for people with high risk neuroblastoma.
This trial is comparing high dose chemotherapy with molecular radiotherapy and chemotherapy for children and young people with neuroblastoma that has spread.
This study is looking at combining mIBG, nivolumab and dinutuximab beta to treat neuroblastoma that has continued to grow during treatment or came back after.
This trial is for children and young adults with cancer that has come back or continued to grow despite treatment.
This trial looked at giving a higher dose of radiotherapy to people with neuroblastoma.
This trial looked at using white blood cells called anti-GD2 T cells to treat neuroblastoma.
This trial looked at nab-paclitaxel for children and young people who have a solid tumour that has not responded to treatment or has come back after treatment.
This trial is to find out more about dancing eye syndrome and its treatment.
This trial was for children and young people with neuroblastoma that was not responding to treatment or had come back.